Blocking the Inflammatory Layer That Triggers Cytokine Storm to Prevent Symptom Worsening!

Those who applied for < Motrex(118990) > hit the upper limit in just 1 day! Achieved 31% profit!

Congratulations to everyone who signed up for the free trial. ^^

※ For those who missed the “COVID-19 treatment,” it’s okay. We are coming out strong once again.

※ Finally starting. Motrex(118990) follow-up stock hits the upper limit on Friday. ※

▶▶ On September 25, starting big with the ‘upper limit’ related to COVID-19 death patient antibodies! ‘ㅇㅇㅇㅇㅇㅇ’ related stocks! ▶ Free trial application ◀

Research shows that antibody therapeutics can prevent the symptoms of COVID patients from worsening. It suppresses the immune overreaction caused by the coronavirus, preventing hospitalized patients from deteriorating to the point of needing a ventilator!!

Genentech in the U.S. announced that among 389 hospitalized patients infected with coronavirus, those who received the antibody therapeutic tocilizumab had a 44% reduction in the number of patients whose symptoms worsened to require ventilators or who died compared to other patients!!

▶▶ Heading straight ‘up’ this Friday. Moving fast. Don’t miss the beneficiary stocks related to COVID-19 death patient antibodies! [Apply now for ‘COVID-19 death patient antibody’ related stocks]

“It was just too difficult to trade stocks alone.” I asked acquaintances for advice here and there, but I never made a proper profit even once. So I thought to get help from an expert and first applied for a 3-day free trial! Wow! Experts really are different. I’m still receiving the service now, and looking back, I think it was a great decision. Thank you very much.

(VIP office worker Kim Minji, 46 years old member)

▶▶ “September 25 upper limit” offered only until today and then closed. [Receive ‘COVID-19 death patient antibody’ related stocks!] ▶ Receive stocks ◀

Think of this as the last chance. If you miss this opportunity, you should quit.

It will explode exactly on “September 25”! Don’t miss it and regret it, and buy at least 1 million KRW worth!

▶▶ Only 30 people! “Friday upper limit”! ▶ Receive now ◀

※ First-come, first-served for 30 people! Both early and late rounds are over. The hero of the final injury time winning goal ※

[Today’s stocks of interest]

#BaxelBio #IlyangPharm #CMGPharm #YoungjinPharm #NextBT

※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.